LumiraDx Limited (LMDX)
0.02
0.00 (25.00%)
At close: Jan 16, 2025, 9:00 PM
undefined% (undefined)
| Bid | n/a |
| Market Cap | 5.10M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.08 |
| PE Ratio (ttm) | -0.01 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | n/a |
| Volume | 120,553,903 |
| Avg. Volume (20D) | 0 |
| Open | 0.02 |
| Previous Close | 0.02 |
| Day's Range | 0.02 - 0.03 |
| 52-Week Range | 0.02 - 0.03 |
| Beta | undefined |
About LMDX
LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has approximately 30 tests on the market and in development covering infectious diseases, cardiovasc...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Mar 19, 2021
Employees 1,210
Stock Exchange NASDAQ
Ticker Symbol LMDX
Website https://www.lumiradx.com
Analyst Forecast
According to 1 analyst ratings, the average rating for LMDX stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%